| [1] |
宋杭洳, 韩晶, 王超, 等. 初治肺结核病人生活质量的影响因素. 护理研究, 2025, 39(20):3384-3391. doi:10.12102/j.issn.1009-6493.2025.20.002.
|
| [2] |
Davies EL, Bulto LN, Walsh A, et al. Reporting and conducting patient journey mapping research in healthcare: A scoping review. J Adv Nurs, 2023, 79(1):83-100. doi:10.1111/jan.15479.
|
| [3] |
中华人民共和国国家卫生和计划生育委员会. WS 196—2017 结核病分类. 结核与肺部疾病杂志, 2024, 5 (4): 379-380. doi:10.19983/j.issn.2096-8493.2024055.
|
| [4] |
Ly S, Runacres F, Poon P. Journey mapping as a novel approach to healthcare: a qualitative mixed methods study in palliative care. BMC Health Serv Res, 2021, 21(1):915. doi:10.1186/s12913-021-06934-y.
pmid: 34479541
|
| [5] |
刘明. Colaizzi七个步骤在现象学研究资料分析中的应用. 护理学杂志, 2019, 34(11):90-92. doi:10.3870/j.issn.1001-4152.2019.11.090.
|
| [6] |
钟倩红, 赵之梦, 张锡林, 等. 《肺结核患者居家治疗管理指南》解读. 中国热带医学, 2022, 22(8):732-734. doi:10.13604/j.cnki.46-1064/r.2022.08.08.
|
| [7] |
乔悦, 刘庆伟, 林辉, 等. 中青年肝移植患者疾病管理的旅程地图研究. 中华护理杂志, 2025, 60(15):1850-1857. doi:10.3761/j.issn.0254-1769.2025.15.009.
|
| [8] |
孔含含, 陈子娇, 曾剑锋, 等. 《肺结核患者症状群评估量表》的编制及信度和效度检验. 中国防痨杂志, 2025, 47(8):1062-1067. doi:10.19982/j.issn.1000-6621.20250080.
|
| [9] |
刘国标, 谭守勇, 龚芳, 等. 无症状肺结核病人的临床特点分析. 临床肺科杂志, 2022, 27(12):1816-1819. doi:10.3969/j.issn.1009-6663.2022.12.008.
|
| [10] |
Zhou Y, Wang F, Chen S, et al. The asymptomatic tuberculosis proportion among the elderly population: a systematic review and meta-analysis. BMC Public Health, 2024, 24(1):3551. doi:10.1186/s12889-024-21019-1.
pmid: 39707254
|
| [11] |
高磊, 成诗明, 金奇, 等. 无症状结核病的隐匿传播与防控策略迭新. 中国防痨杂志, 2025, 47(9):1135-1139. doi:10.19982/j.issn.1000-6621.20250305.
|
| [12] |
姜晓颖, 张文, 高孟秋, 等. 初治病原学阳性肺结核患者结核病防治核心信息知晓情况调查. 中国防痨杂志, 2023, 45(8):794-800. doi:10.19982/j.issn.1000-6621.20230090.
|
| [13] |
Abebe G, Deribew A, Apers L, et al. Knowledge, health seeking behavior and perceived stigma towards tuberculosis among tuberculosis suspects in a rural community in southwest Ethiopia. PLoS One, 2010, 5(10):e13339. doi:10.1371/journal.pone.0013339.
|
| [14] |
Hoa NB, Tiemersma EW, Sy DN, et al. Health-seeking behaviour among adults with prolonged cough in Vietnam. Trop Med Int Health, 2011, 16(10):1260-1267. doi:10.1111/j.1365-3156.2011.02823.x.
|
| [15] |
潘陈丽, 徐九云. 耐多药肺结核患者心理行为的质性研究. 护理学杂志, 2015, 30(5):38-40. doi:10.3870/hlxzz.2015.05.03.
|
| [16] |
成小清, 袁丹, 彭新景. 肺结核患者抗结核治疗期间病耻感对遵医行为的影响:健康信念的纵向中介作用. 中国防痨杂志, 2025, 47(9):1154-1161. doi:10.19982/j.issn.1000-6621.20250158.
|
| [17] |
Milice DM, Macicame I, L Peñalvo J. The collaborative framework for the management of tuberculosis and type 2 diabetes syndemic in low- and middle-income countries: a rapid review. BMC Public Health, 2024, 24(1):738. doi:10.1186/s12889-024-18256-9.
|
| [18] |
Zumla A, Abubakar I, Raviglione M, et al. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis, 2012, 2:S228-240. doi:10.1093/infdis/jir858.
|
| [19] |
Meghji J, Mortimer K, Agusti A, et al. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet, 2021, 397:928-940. doi:10.1016/S0140-6736(21)00458-X.
pmid: 33631128
|
| [20] |
Olowoyo KS, Esan DT, Adeyanju BT, et al. Telemedicine as a tool to prevent multi-drug resistant tuberculosis in poor resource settings: Lessons from Nigeria. J Clin Tuberc Other Mycobact Dis, 2024, 35:100423. doi:10.1016/j.jctube.2024.100423.
|
| [21] |
Nsengiyumva NP, Mappin-Kasirer B, Oxlade O, et al. Evalua-ting the potential costs and impact of digital health technologies for tuberculosis treatment support. Eur Respir J, 2018, 52(5):1801363. doi:10.1183/13993003.01363-2018.
|
| [22] |
Kumar AA, De Costa A, Das A, et al. Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative? JMIR Mhealth Uhealth, 2019, 7(4):e11687. doi:10.2196/11687.
|
| [23] |
Bedard BA, Younge M, Pettit PA, et al. Using Telemedicine for Tuberculosis Care Management: a Three County Inter-Municipal Approach. J Med Syst, 2017, 42(1):12. doi:10.1007/s10916-017-0872-7.
pmid: 29181590
|
| [24] |
Wei X, Hicks JP, Zhang Z, et al. Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial. Lancet, 2024, 403(10430):913-923. doi:10.1016/S0140-6736(23)02270-5.
pmid: 38309280
|